185 related articles for article (PubMed ID: 5134893)
1. Hypertension and low plasma renin activity: presumptive evidence for mineralocorticoid excess.
Spark RF; Melby JC
Ann Intern Med; 1971 Dec; 75(6):831-6. PubMed ID: 5134893
[No Abstract] [Full Text] [Related]
2. Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin.
Brown JJ; Davies DL; Ferriss JB; Fraser R; Haywood E; Lever AF; Robertson JI
Br Med J; 1972 Jun; 2(5816):729-34. PubMed ID: 4338668
[TBL] [Abstract][Full Text] [Related]
3. The use of spironolactone in the diagnosis and the treatment of hypertension associated with mineralocorticoid excess.
Beevers DG; Brown JJ; Ferriss JB; Fraser R; Lever AF; Robertson JI
Am Heart J; 1973 Sep; 86(3):404-14. PubMed ID: 4592546
[No Abstract] [Full Text] [Related]
4. Dexamethasone-responsive hypertension in young women with suppressed renin and aldosterone.
Hoefnagels WH; Drayer JI; Hofman JA; Kloppenborg PW; Smals AG; Benraad TJ
Lancet; 1978 Apr; 1(8067):741-3. PubMed ID: 76749
[TBL] [Abstract][Full Text] [Related]
5. Hypertension with aldosterone excess and low plasma-renin: preoperative distinction between patients with and without adrenocortical tumour.
Ferriss JB; Brown JJ; Fraser R; Kay AW; Neville AM; O'Muircheartaigh IG; Robertson JI; Symington T; Lever AF
Lancet; 1970 Nov; 2(7681):995-1000. PubMed ID: 4098088
[No Abstract] [Full Text] [Related]
6. 18-Hydroxy-deoxycorticosterone in human hypertension.
Melby JC; Dale SL; Wilson TE
Circ Res; 1971 May; 28(5):Suppl 2:143-52. PubMed ID: 4327960
[No Abstract] [Full Text] [Related]
7. Spironolactone in essential hypertension: evidence against its effect through mineralocorticoid antagonism.
Hoffbrand BI; Edmonds CJ; Smith T
Br Med J; 1976 Mar; 1(6011):682-4. PubMed ID: 766908
[TBL] [Abstract][Full Text] [Related]
8. New aspects of mineralocorticoid hypertension.
Mantero F; Armanini D; Biason A; Boscaro M; Carpenè G; Fallo F; Opocher G; Rocco S; Scaroni C; Sonino N
Horm Res; 1990; 34(3-4):175-80. PubMed ID: 2151775
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess.
Oberfield SE; Levine LS; Carey RM; Greig F; Ulick S; New MI
J Clin Endocrinol Metab; 1983 Feb; 56(2):332-9. PubMed ID: 6296185
[TBL] [Abstract][Full Text] [Related]
10. Effect of high dose spironolactone and chlorthalidone in essential hypertension: relation to plasma renin activity and plasma volume.
Hunyor SN; Zweifler AJ; Hansson L; Schork MA; Ellis C
Aust N Z J Med; 1975 Feb; 5(1):17-24. PubMed ID: 1057909
[TBL] [Abstract][Full Text] [Related]
11. Sodium and the renin-angiotensin system in essential hypertension and mineralocorticoid excess.
Lebel M; Schalekamp MA; Beevers DG; Brown JJ; Davies DL; Fraser R; Kremer D; Lever AF; Morton JJ; Robertson JI; Tree M; Wilson A
Lancet; 1974 Aug; 2(7876):308-9. PubMed ID: 4136047
[No Abstract] [Full Text] [Related]
12. Plasma renin activity and in vitro synthesis of aldosterone by the adrenal glands of rats with spontaneous, renal, or pinealectomy-induced hypertension.
Karppanen H; Lahovaara S; Männistö P; Vapaatalo H
Acta Physiol Scand; 1975 Jun; 94(2):184-8. PubMed ID: 168735
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and hyperaldosteronism with low plasma renin concentration: analysis of a series of eighty-two patients.
Brown JJ; Chinn RH; Düsterdieck GO; Fraser R; Gleadle RH; Lever AF; Robertson JI; Tree M
Proc R Soc Med; 1969 Dec; 62(12):1258-60. PubMed ID: 5363111
[No Abstract] [Full Text] [Related]
14. Bilateral adrenal hyperplasia as a cause of primary aldosteronism with hypertension, hypokalemia and suppressed renin activity.
Davis WW; Newsome HH; Wright LD; Hammond WG; Easton J; Bartter FC
Am J Med; 1967 Apr; 42(4):642-7. PubMed ID: 6024721
[No Abstract] [Full Text] [Related]
15. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension.
New MI; Levine LS; Biglieri EG; Pareira J; Ulick S
J Clin Endocrinol Metab; 1977 May; 44(5):924-33. PubMed ID: 870517
[TBL] [Abstract][Full Text] [Related]
16. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration.
Ferriss JB; Brown JJ; Fraser R; Haywood E; Davies DL; Kay AW; Lever AF; Robertson JI; Owen K; Peart WS
Br Med J; 1975 Jan; 1(5950):135-8. PubMed ID: 234268
[TBL] [Abstract][Full Text] [Related]
17. New findings in apparent mineralocorticoid excess.
DiMartino-Nardi J; Stoner E; Martin K; Balfe JW; Jose PA; New MI
Clin Endocrinol (Oxf); 1987 Jul; 27(1):49-62. PubMed ID: 2820623
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive effect of spironolactone in essential, renal and mineralocorticoid hypertension.
Mantero F; Armanini D; Urbani S
Clin Sci Mol Med Suppl; 1973 Aug; 45 Suppl 1():219s-24. PubMed ID: 4522169
[No Abstract] [Full Text] [Related]
19. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
Wisgerhof M; Brown RD
J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
[TBL] [Abstract][Full Text] [Related]
20. Genetics of the mineralocorticoid system in primary hypertension.
Ferrari P
Curr Hypertens Rep; 2002 Feb; 4(1):18-24. PubMed ID: 11790287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
